title: Can the combination of ALSFRS and survival time analysis impact the outcome in phase III ALS clinical trials?
authors.forename: Raghav
authors.initials: R
authors.lastname: Govindarajan
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000401:mortality* / Q000628:therapy*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods*